Refactory has strategically invested in Bleicher GmbH to enhance lifecycle services in medical technology, particularly in enteral nutrition, while also ensuring smooth succession planning.
Target Information
The Bleicher GmbH is a prominent provider of refurbishment solutions for medical technology, particularly in the field of enteral nutrition. The company is responsible for the complete revitalization and quality assurance of devices used in medical care. These highly specialized services significantly contribute to extending the lifecycle of devices while ensuring the highest standards of safety and quality.
The experienced B2B service provider specializes in the assembly of electromechanical components, cable assembly, and comprehensive lifecycle services. With over 20 years of industry experience, Bleicher GmbH primarily supports clients from the medical technology, manufacturing, automotive, and logistics sectors. Their extensive range of services also includes small series production, repair and maintenance services, and quality assurance for electromechanical components. Additionally, Bleicher takes on responsibilities in procurement, pre-financing, and warehousing to optimally support customers throughout the entire product lifecycle.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
With a team of 20 experts, the company manages approximately 900 repairs monthly and has produced over one million components to date. The Bleic
Similar Deals
athagoras → DiaMed Beratungsgesellschaft für pharmazeutische Unternehmen mbH
2025
refactory
invested in
Bleicher GmbH
in 2025
in a Other deal